TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Why B.C.’s Distribution and Retail Plan Should Worry Cannabis Investors

Tech Stocks
Why Shopify Inc. Was up 7% Yesterday
Investing
Why Canopy Growth Corp. Will Hit $50 This Year
Investing
MedReleaf Corp. Launches Recreational Cannabis Brand: San Rafael ’71
Investing
Cannabis Investors: Put These 2 Stocks in Your Pipe and Smoke Them
Investing
Marijuana Stocks: A Performance Review and a Look Ahead

Stocks for Beginners
Are You a New Investor Who’s Interested in Marijuana Stocks? Read This!

Stocks for Beginners
Are Marijuana Stocks the Right Choice in the Current Market Environment?
Investing
Why You Shouldn’t Expect Pot to Be Legalized by July
Investing
Canopy Growth Corp.: Is it a Buy at $27?

Investing
The TSX Is Down Again: Why it Could Get Even Worse
